Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Sever Pharma Solutions AB

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 57,119 Less Arrow 54,807 Less Arrow 46,726
Financial expenses 497 More Arrow 518 Less Arrow 391
Earnings before taxes -2,123 More Arrow 1,517 More Arrow 2,734
EBITDA 735 More Arrow 4,013 More Arrow 4,773
Total assets 57,410 Less Arrow 49,151 Less Arrow 44,559
Current assets 31,146 Less Arrow 25,091 Less Arrow 19,277
Current liabilities 19,585 Less Arrow 17,409 Less Arrow 9,218
Equity capital 36,244 Less Arrow 29,713 Less Arrow 22,256
- share capital 901 Less Arrow 899 More Arrow 978
Employees (average) 322 Less Arrow 312 Less Arrow 278

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 63.1% Less Arrow 60.5% Less Arrow 49.9%
Turnover per employee 177 Less Arrow 176 Less Arrow 168
Profit as a percentage of turnover -3.7% More Arrow 2.8% More Arrow 5.9%
Return on assets (ROA) -2.8% More Arrow 4.1% More Arrow 7.0%
Current ratio 159.0% Less Arrow 144.1% More Arrow 209.1%
Return on equity (ROE) -5.9% More Arrow 5.1% More Arrow 12.3%
Change turnover 2,153 More Arrow 11,866 Less Arrow 3,661
Change turnover % 4% More Arrow 28% Less Arrow 9%
Chg. No. of employees 10 More Arrow 34 Less Arrow 22
Chg. No. of employees % 3% More Arrow 12% Less Arrow 9%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.